Large-scale testing (Phase 3)Active Not RecruitingNCT03814746
What this trial is testing
Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
Who this might be right for
Sickle Cell Disease (SCD)
Novartis Pharmaceuticals 254